head and neck cancer Jul 27, 2022 Nutcracker Therapeutics Aims to Beat HPV-Driven Cancers With Multimodal mRNA Therapeutics Premium Jul 11, 2022 Immune Checkpoint Blockade Response Linked to Recurrent Mutations in Genes, Pathways Jul 6, 2022 Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition May 11, 2022 FDA Accepts Cue Biopharma's IND for CUE-102 in WT1-Expressing Cancers Apr 20, 2022 BeiGene Updates Phase III Data, Biomarker Analysis for Anti-PD-1 Drug in Nasopharyngeal Cancer Apr 19, 2022 PDS Biotechnology Nets $1.2M Through NJ Economic Development Program to Advance Oncology Candidates Feb 17, 2022 New Data Further Validates Inivata's MRD Test as Company Prepares Commercial Launch Premium Feb 15, 2022 Mayo Clinic Exploring PDS Biotech's PDS0101, Merck's Keytruda in HPV-Associated Oropharyngeal Cancer Feb 11, 2022 Seattle Cancer Care Alliance Aims to Improve Molecular Profiling Access for Thyroid Cancer Patients Premium Dec 16, 2021 Kura Oncology Begins Trial of Tipifarnib, Novartis' Piqray in Head and Neck Cancer Dec 3, 2021 I-Mab Begins Study of Uliledlimab Plus Tecentriq in Advanced Solid Tumors Aug 19, 2021 TERT Promoter Mutations Linked to Higher Recurrence Risk in Oral Cavity Cancers Premium Jul 16, 2021 In Brief This Week: Strata Oncology, Ideaya Biosciences, Children's Cancer Institute Australia, BMS Jul 6, 2021 Novartis, Kura Oncology Partner on Phase I/II Head and Neck Cancer Study of Piqray, Tipifarnib Apr 15, 2021 OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer Apr 13, 2021 Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay Mar 23, 2021 European Consortium Wins €6.9M Grant to Develop HPV16-Positive Cancer Vaccine Mar 16, 2021 Abviris Raises Almost $2.4M to Expand Use of HPV-Related Cancer Test Mar 15, 2021 Bicara Therapeutics Launches With $40M Seed Funding, Bifunctional Antibody Pipeline Mar 3, 2021 After Setbacks, Innate Pharma on Track to Advance NK Cell-based Immunotherapy Pipeline Premium Load More Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
